Todd P. Kelsey Sells 1,500 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXS - Get Free Report) CEO Todd P. Kelsey sold 1,500 shares of the business's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $129.87, for a total value of $194,805.00. Following the sale, the chief executive officer now owns 75,214 shares in the company, valued at approximately $9,768,042.18. The trade was a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Plexus Price Performance

NASDAQ PLXS traded up $1.37 during trading on Friday, reaching $132.86. The company's stock had a trading volume of 99,141 shares, compared to its average volume of 168,788. The stock has a market capitalization of $3.60 billion, a PE ratio of 30.83 and a beta of 0.81. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The firm has a fifty day moving average of $126.11 and a 200 day moving average of $140.53. Plexus Corp. has a one year low of $100.96 and a one year high of $172.89.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.12. The business had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. Plexus had a return on equity of 10.36% and a net margin of 3.03%. The company's quarterly revenue was up 1.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.94 EPS. Analysts expect that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on PLXS. Needham & Company LLC reiterated a "buy" rating and set a $162.00 price objective (down from $172.00) on shares of Plexus in a research note on Friday, April 25th. Stifel Nicolaus set a $145.00 price objective on Plexus in a research note on Thursday, April 24th. Finally, Benchmark reiterated a "buy" rating and set a $160.00 price objective on shares of Plexus in a research note on Wednesday. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $155.67.

Hedge Funds Weigh In On Plexus

Several institutional investors have recently modified their holdings of the company. American Century Companies Inc. boosted its holdings in Plexus by 72.2% during the 4th quarter. American Century Companies Inc. now owns 544,017 shares of the technology company's stock valued at $85,128,000 after acquiring an additional 228,027 shares during the period. Fuller & Thaler Asset Management Inc. boosted its holdings in Plexus by 120.4% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company's stock valued at $44,655,000 after acquiring an additional 190,360 shares during the period. Nuveen LLC purchased a new stake in Plexus during the 1st quarter valued at about $22,975,000. GAMMA Investing LLC boosted its holdings in Plexus by 19,069.1% during the 1st quarter. GAMMA Investing LLC now owns 170,797 shares of the technology company's stock valued at $21,884,000 after acquiring an additional 169,906 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in Plexus by 146.9% during the 4th quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company's stock valued at $40,501,000 after acquiring an additional 154,003 shares during the period. 94.45% of the stock is currently owned by institutional investors.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.